National News
Bipartisan Senate Bill Aims to Secure American Labs with the Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act
Content Files PDF XML TEXT Metadata download Descriptive Metadata (MODS) Preservation Metadata (PREMIS) All Content and Metadata files, including granules ZIP
Last updated:
Key points
- The bipartisan bill designates biotechnology and biomanufacturing as critical infrastructure under CISA protection.
- Lawmakers introduced the legislation in response to recommendations from the National Security Commission on Emerging Biotechnology.
- The bill bridges existing gaps by protecting biological assets that fall outside the 16 current critical infrastructure sectors.
NewsWK — Congress is moving to shield the nation’s advanced science sectors from emerging security threats. On September 24, 2026, lawmakers introduced a bipartisan bill to expand federal oversight of vital biological facilities.
Why it matters
This legislative move directly impacts national security and the domestic supply chain. Biotechnology drives critical advancements in medicine, agriculture, and manufacturing. However, many of these facilities currently lack dedicated federal protection under existing security frameworks. This bill closes those gaps to safeguard American innovation.
How Will the S 5502 Biotechnology Bill Safeguard American Labs?
The proposed law directs the Cybersecurity and Infrastructure Security Agency (CISA) to defend vital biological assets. CISA must identify industry stakeholders and create outreach plans. Consequently, this crucial initiative integrates biotechnology and biomanufacturing into the nation’s primary security framework.
Currently, the federal government recognizes 16 critical infrastructure sectors. However, many biotechnology assets do not fit into these categories. The new legislation addresses this issue through several key mandates:
- Amends the Homeland Security Act of 2002 to expand CISA’s authority.
- Requires CISA to develop strategic protection plans for biological facilities.
- Integrates biomanufacturing into national security frameworks.
Who Is Behind the New Biotechnology Critical Infrastructure Legislation?
A bipartisan coalition in Congress is leading this legislative effort. Senator Maggie Hassan (D-NH) introduced the Senate bill alongside Senator Todd Young. This collaboration highlights the importance of Senator Todd Young biomanufacturing protections. Meanwhile, Representative Ro Khanna (D-CA) introduced a companion bill in the House of Representatives.
Why Did Lawmakers Introduce the Senator Maggie Hassan Biotechnology Bill Now?
Congressmen introduced the bill following urgent recommendations from the National Security Commission on Emerging Biotechnology. Lawmakers paired this legislation with another bill called the Protecting Biological Data as Critical Infrastructure Act. Together, these bills aim to protect sensitive biological data and physical infrastructure.
This article was produced with the assistance of AI and reviewed by our editorial team.
Sources
Related: House Resolution 1499 Clears Way for Critical Votes on Mining, Higher Education, and Maritime Rules
See a typo? Report it here.
